New Fixed‐Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High‐Risk Patients with Mixed Dyslipidemia Versus Monotherapies

Publisher: John Wiley & Sons Inc

E-ISSN: 1755-5922|33|6|329-337

ISSN: 1755-5914

Source: CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.33, Iss.6, 2015-12, pp. : 329-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content